Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OT-101 in pediatric myopia progression
NCT04770610Phase 3Active, not recruiting
- Sponsor
- Ocumension Biotech
- Start
- Apr 2021
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 3 trial of trabedersen in myopia, sponsored by Ocumension Biotech. Started Apr 2021; status: active, not recruiting.
02
Drugs
trabedersen
03
Conditions
myopia
Beyond the preview
Go deeper on NCT04770610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04770610.